Metachronous Merkel cell carcinoma on both cheeks. Acta Derm Venereol. 2012 Nov;92(6):633; author reply p.634.
Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials
Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer
